SG Americas Securities’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $623K | Buy |
21,930
+4,440
| +25% | +$126K | ﹤0.01% | 1362 |
|
|
2025
Q1 | $516K | Buy |
+17,490
| New | +$516K | ﹤0.01% | 1569 |
|
|
2024
Q4 | – | Sell |
-12,675
| Closed | -$582K | – | 3062 |
|
|
2024
Q3 | $582K | Sell |
12,675
-83,604
| -87% | -$3.84M | ﹤0.01% | 1364 |
|
|
2024
Q2 | $3.93M | Buy |
96,279
+91,870
| +2,084% | +$3.75M | 0.02% | 613 |
|
|
2024
Q1 | $113K | Sell |
4,409
-37,296
| -89% | -$956K | ﹤0.01% | 2191 |
|
|
2023
Q4 | $377K | Buy |
+41,705
| New | +$377K | ﹤0.01% | 1488 |
|
|
2023
Q2 | – | Sell |
-26,097
| Closed | -$401K | – | 2670 |
|
|
2023
Q1 | $401K | Buy |
26,097
+7,406
| +40% | +$114K | ﹤0.01% | 1717 |
|
|
2022
Q4 | $415K | Buy |
18,691
+1,635
| +10% | +$36.3K | 0.01% | 1501 |
|
|
2022
Q3 | $279K | Sell |
17,056
-14,069
| -45% | -$230K | ﹤0.01% | 1822 |
|
|
2022
Q2 | $452K | Buy |
+31,125
| New | +$452K | ﹤0.01% | 1858 |
|
|
2022
Q1 | – | Sell |
-10,307
| Closed | -$245K | – | 2906 |
|
|
2021
Q4 | $245K | Sell |
10,307
-14,351
| -58% | -$341K | ﹤0.01% | 2313 |
|
|
2021
Q3 | $607K | Sell |
24,658
-2,843
| -10% | -$70K | ﹤0.01% | 2143 |
|
|
2021
Q2 | $680K | Sell |
27,501
-3,033
| -10% | -$75K | ﹤0.01% | 1616 |
|
|
2021
Q1 | $666K | Buy |
+30,534
| New | +$666K | ﹤0.01% | 1642 |
|